Why CRISPR Therapeutics AG Stock Lost Ground in September – Motley Fool
Simply Wall St |
Why CRISPR Therapeutics AG Stock Lost Ground in September
Motley Fool According to data from S&P Global Market Intelligence, shares of the gene-editing company CRISPR Therapeutics (NASDAQ:CRSP) dropped by 13.1% in September. CRISPR's poor showing last month appears to stem from nothing more than investors … Next Capital Raising For CRISPR Therapeutics AG (CRSP)? Street Analysts View On CRISPR Therapeutics AG (CRSP), China Life Insurance Company Limited (LFC) Crispr Therapeutics AG (CRSP) Expected to Announce Earnings of -$0.49 Per Share |
